EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway

Wei Hu, Yaorui Hu, Yao Pei, Rongrong Li, Fuyi Xu, Xiaodong Chi, Jia Mi, Jonas Bergquist iD, Lu Lu, Luping Zhang, Chunhua Yang

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24010861 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Wei Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, China. Hauptthemen laut MEDLINE: Carcinoma, Ubiquitin-Protein Ligases, Uterine Cervical Neoplasms, Gene Silencing. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Fundation of Shandong Province, BZMC Scientific Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical carcinoma (CC) is the second most prevalent gynecologic cancer in females across the world. To obtain a better understanding of the mechanisms underlying the development of CC, high-resolution label-free mass spectrometry was performed on CC and adjacent normal tissues from eight patients. A total of 2631 proteins were identified, and 46 significant differently expressed proteins (DEPs) were found between CC and normal tissues (p < 0.01, fold change >10 or

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinomaUbiquitin-Protein LigasesUterine Cervical NeoplasmsGene SilencingFemaleHumansApoptosisCell Line, TumorCell MovementCell ProliferationCisplatinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionTOR Serine-Threonine Kinases

Stichwörter der Autor:innen

Deltex-3-likePI3K/AKT/mTOR signaling pathwaycervical carcinoma (CC)quantitative proteomicstherapeutic target

Substanzen

CisplatinDTX3L protein, humanMTOR protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, China.
  • Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, School of Pharmacy, Binzhou Medical University, Yantai 264000, China.
  • School of Basic Medicine, Binzhou Medical University, Yantai 264000, China.
  • Department of Chemistry-BMC, Analytical Chemistry and Neurochemistry, Uppsala University, 75124 Uppsala, Sweden.
  • Department of Genetics, Genomics and Informatics, The University of Tennessee Health Science Center, Memphis, TN 38163, USA.

ORCID-Profile: Jonas Bergquist

Förderung

  • National Natural Science Foundation of China
  • Natural Science Fundation of Shandong Province
  • BZMC Scientific Research Foundation
  • Taishan Scholars Construction Engineering
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Hu, W., Hu, Y., Pei, Y., Li, R., Xu, F., Chi, X., Mi, J., Bergquist, J., Lu, L., Zhang, L., & Yang, C. (2023). Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24010861

Vancouver

Hu W, Hu Y, Pei Y, Li R, Xu F, Chi X, et al. Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24010861

BibTeX
@article{Hu2023,
  author = {Hu, Wei and Hu, Yaorui and Pei, Yao and Li, Rongrong and Xu, Fuyi and Chi, Xiaodong and Mi, Jia and Bergquist, Jonas and Lu, Lu and Zhang, Luping and Yang, Chunhua},
  title = {Silencing DTX3L Inhibits the Progression of Cervical Carcinoma by Regulating PI3K/AKT/mTOR Signaling Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24010861}
}
Kostenlos starten →